These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9193356)

  • 1. Secondary acute myelogenous leukemia following safe exposure to etoposide.
    Stine KC; Saylors RL; Sawyer JR; Becton DL
    J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
    Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
    [No Abstract]   [Full Text] [Related]  

  • 3. High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
    Sugita K; Furukawa T; Tsuchida M; Okawa Y; Nakazawa S; Akatsuka J; Ohira M; Nishimura K
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):99-104. PubMed ID: 8447565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide].
    Kikuta T; Shimazaki C; Hirai H; Sumikuma T; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Fujita N; Hatta T; Nakagawa M
    Rinsho Ketsueki; 1996 Nov; 37(11):1276-82. PubMed ID: 8960661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
    Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Teramura T; Kuriyama K; Kitazawa J; Ito E; Morimoto A; Hibi S
    Int J Hematol; 2002 Feb; 75(2):174-7. PubMed ID: 11939264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis.
    Henter JI; Elinder G; Lübeck PO; Ost A
    Pediatr Hematol Oncol; 1993; 10(2):163-8. PubMed ID: 8318372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.
    Yagita M; Ieki Y; Onishi R; Huang CL; Adachi M; Horiike S; Konaka Y; Taki T; Miyake M
    Int J Oncol; 1998 Jul; 13(1):91-6. PubMed ID: 9625808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary acute myelogenous leukemia following treatment with oral etoposide.
    Katato K; Flaherty L; Varterasian M
    Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
    Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
    J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
    Gombos DS; Hungerford J; Abramson DH; Kingston J; Chantada G; Dunkel IJ; Antoneli CB; Greenwald M; Haik BG; Leal CA; Medina-Sanson A; Schefler AC; Veerakul G; Wieland R; Bornfeld N; Wilson MW; Yu CB
    Ophthalmology; 2007 Jul; 114(7):1378-83. PubMed ID: 17613328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Small cell lung cancer with acute monocytic leukemia after combined chemotherapy including etoposide].
    Tamada T; Kimura K; Tabata M; Ishimori S; Tsuburaya T; Hayashi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):577-82. PubMed ID: 9234639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome.
    Takahashi T; Yagasaki F; Endo K; Takahashi M; Itoh Y; Kawai N; Kusumoto S; Murohashi I; Bessho M; Hirashima K
    Int J Hematol; 1998 Oct; 68(3):333-6. PubMed ID: 9846019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy].
    Kamai T; Touma T; Masuda H; Hyouchi N; Okuno T; Yonese J; Fukuda H; Tachibana Y; Ishiwata D
    Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):875-9. PubMed ID: 8691713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
    Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
    Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
    Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
    Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral etoposide for recurrent/progressive sarcomas of childhood.
    Kebudi R; Görgün O; Ayan I
    Pediatr Blood Cancer; 2004 Apr; 42(4):320-4. PubMed ID: 14966827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.